Evidence map›Paper›PMID 28949262›Full record

ReviewInternational journal of audiology2018

Monitoring neonates for ototoxicity.

Angela C Garinis, Alison Kemph, Anne Marie Tharpe, Joern-Hendrik Weitkamp, Cynthia McEvoy, Peter S Steyger

Abstract readReview
In one paragraph

Review in International journal of audiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Advances in Inner Ear Therapeutics for Hearing Loss in Children.Current otorhinolaryngology reports · 2020
    Article
  10. Review
  11. Ototoxicity: Visualized in Concept Maps.Seminars in hearing · 2019
    Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Angela C Garinisa Oregon Hearing Research Center, Otolaryngology , Oregon Health & Science University , Portland , OR , USA.ORCID 0000-0002-6088-6603
Alison Kemphc Hearing and Speech Sciences , Vanderbilt University School of Medicine , Nashville , TN , USA.
Anne Marie Tharpec Hearing and Speech Sciences , Vanderbilt University School of Medicine , Nashville , TN , USA.
Joern-Hendrik Weitkampd Pediatrics , Vanderbilt University School of Medicine , Nashville , TN , USA , and.ORCID 0000-0002-7751-2122
Cynthia McEvoye Neonatology, Pediatrics , Oregon Health & Science University , Portland , OR , USA.ORCID 0000-0001-8501-8813
Peter S Steygera Oregon Hearing Research Center, Otolaryngology , Oregon Health & Science University , Portland , OR , USA.ORCID 0000-0002-6103-5237

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
HAIR CELL RESPONSES TO OTOTOXIC DRUGSR01DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2001 to 2020
$6.6M
Ameliorating systemic gentamicin uptake by sensory hair cellsR01DC012588 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2012 to 2016
$2.0M
Hair cell responses to ototoxic drugsR56DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2007 to 2007
$385k
NCATS NIH HHS UL1 TR000128NCATS NIH HHS UL1 TR002369NIDCD NIH HHS R01 DC004555NIDCD NIH HHS R01 DC012588NIDCD NIH HHS R56 DC004555
6 · The paper itself

Abstract

objectivesNeonates admitted to the neonatal intensive care unit (NICU) are at greater risk of permanent hearing loss compared to infants in well mother and baby units. Several factors have been associated with this increased prevalence of hearing loss, including congenital infections (e.g. cytomegalovirus or syphilis), ototoxic drugs (such as aminoglycoside or glycopeptide antibiotics), low birth weight, hypoxia and length of stay. The aetiology of this increased prevalence of hearing loss remains poorly understood.

designHere we review current practice and discuss the feasibility of designing improved ototoxicity screening and monitoring protocols to better identify acquired, drug-induced hearing loss in NICU neonates. STUDY SAMPLE: A review of published literature.

conclusionsWe conclude that current audiological screening or monitoring protocols for neonates are not designed to adequately detect early onset of ototoxicity. This paper offers a detailed review of evidence-based research, and offers recommendations for developing and implementing an ototoxicity monitoring protocol for young infants, before and after discharge from the hospital.

Indexed as

Hearing TestsAge FactorsChild, PreschoolDose-Response Relationship, DrugDrug InteractionsDrug MonitoringEarly DiagnosisHearingHearing LossHumansInfantInfant, NewbornIntensive Care Units, NeonatalPredictive Value of TestsRisk AssessmentRisk Factorsanatomy and physiologyconditions/pathology/disordersNewborn hearing screeningpaediatric

Identifiers

PMID28949262
PMCPMC5741535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.